InsiderClue
Insiders · Profile

Janku Filip

Chief Medical Officer at Monte Rosa Therapeutics. Filing since 5 Jan 2026. CIK 0001862930

Company
Date
Role
Action
Shares
Amount
Of holding
GLUE Monte Rosa Therapeutics, Inc.
30 Jun 2026
Chief Medical Officer
Sold on a plan
5,407
$132.47K
8.2%
GLUE Monte Rosa Therapeutics, Inc.
29 Jun 2026
Chief Medical Officer
Sold on a plan
6,000
$137.70K
9.1%
GLUE Monte Rosa Therapeutics, Inc.
24 Jun 2026
Chief Medical Officer
Sold on a plan
30,000
$642.68K
33.3%
GLUE Monte Rosa Therapeutics, Inc.
23 Jun 2026
Chief Medical Officer
Sold on a plan
11,845
$239.52K
16.5%
GLUE Monte Rosa Therapeutics, Inc.
23 Feb 2026
Chief Medical Officer
Sold at will
9,189
$179.16K
12.2%
GLUE Monte Rosa Therapeutics, Inc.
5 Jan 2026
Chief Medical Officer
Sold at will
3,155
$47.86K
4.0%
6 decisions on file.